Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Atherosclerosis|January 11, 2007
Atherosclerosis risk factors in children of parents with the metabolic syndromeGulcin Akinci, Senol Coskun, Baris Akinci, et al.
Pediatric Neurology|April 19, 2014
Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan geneGulden Diniz, Hulya Tosun Yildirim, Gulcin Akinci, et al.
JIMD Reports|July 12, 2018
The Second Case of Saposin A Deficiency and Altered AutophagyMelis Kose, Secil Akyildiz Demir, Gulcin Akinci, et al.
JCI Insight|May 24, 2021
The determinants of complication trajectories in American Indians with type 2 diabetesEvan L Reynolds, Gulcin Akinci, Mousumi Banerjee, et al.
European Journal of Medical Genetics|May 12, 2016
Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4Gulcin Akinci, Haluk Topaloglu, Baris Akinci, et al.
Obesity (Silver Spring, Md.)|November 8, 2021
Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatologyBrian C Callaghan, Evan L Reynolds, Mousumi Banerjee, et al.
Endocrine Research|September 6, 2018
A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalitiesBasak Ozgen Saydam, Melda Sonmez, Ilgin Yildirim Simsir, et al.
Neuromuscular Disorders : NMD|July 30, 2017
Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter studyGulcin Akinci, Haluk Topaloglu, Tevfik Demir, et al.
Metabolism: Clinical and Experimental|July 4, 2015
Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalitiesBaris Akinci, Fatos Dilan Koseoglu, Huseyin Onay, et al.
Metabolism: Clinical and Experimental|June 24, 2017
Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophyBaris Akinci, Huseyin Onay, Tevfik Demir, et al.
Pageof 3